EGFR and cancer: In addition, certain recurring mutations in PI3K subunits that drive oncogenesis could render PI3K activity more sensitive to the increased pHi of cancer cells, such as occurs in documented pH sensors (e.g., epidermal growth factor receptor, p53, β-catenin) bearing charge-changing Arg to His mutations (44, 80, 81).